Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption
Mohanraj Rajesh(Institute of Medical Sciences), Pál Pacher(National Institutes of Health)
American Journal of Physiology-Heart and Circulatory Physiology
March 24, 2007
Cited by 208
Related Papers
Activation of the Peripheral Endocannabinoid System in Human Obesity
|Diabetes|2005|690
Potent Metalloporphyrin Peroxynitrite Decomposition Catalyst Protects Against the Development of Doxorubicin-Induced Cardiac Dysfunction
|Circulation|2003|277
Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death
|Journal of Pharmacology and Experimental Therapeutics|2008|248
Cannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic Cardiomyopathy
|Diabetes|2012|248
Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases
|British Journal of Pharmacology|2017|210